 Novo Integrated Sciences Inc NASDAQ: NVOS has acquired 91 of Terragenx through an all-share transaction at 3.35 per share. The human immune system uses iodine to deactivate viruses in the bloodstream, facilitating the production of antibodies for various indications. 